← Eichor
Study identifier: NCT07481266 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Single-Window Versus Two-Window Posterolateral Approach for Malleolar Fractures

Condition: Ankle Fractures · Posterior Malleolus Fractures · Lateral Malleolus Fracture  ·  Sponsor: muhammed kılıç

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this prospective clinical trial is to compare the clinical outcomes and early wound complication rates of two different surgical techniques used during the posterolateral approach for ankle fractures. Participants with fractures involving the posterior and lateral malleoli will undergo surgery using either a single-window technique (using a posterior antiglide plate) or a two-window technique (using a lateral anatomic plate). The main question the study aims to answer is whether the single-window approach reduces soft-tissue complications by minimizing surgical dissection, without compromising fracture stability. Patients will be followed for 12 months to assess wound healing, ankle range of motion, implant irritation, and functional recovery.

This description comes directly from the study's public registry record.

Talk to the study team

Muhammed Kilic, MD  ·  +905077707553  ·  dr.kilic.06@gmail.com

Fatih İnci, Assoc Prof  ·  +905052325821  ·  fatihinci@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara Bilkent City HospitalAnkara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07481266